» Articles » PMID: 21446722

PH-dependent Structures of Ferritin and Apoferritin in Solution: Disassembly and Reassembly

Overview
Date 2011 Mar 31
PMID 21446722
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

The pH-dependent structures of the ferritin shell (apoferritin, 24-mer) and the ferrihydrite core, under physiological conditions that permit enzymatic activity, were investigated by synchrotron small-angle X-ray scattering (SAXS). The solution structure of apoferritin was found to be nearly identical to the crystal structure. The shell thickness and hollow core volumes were estimated. The intact hollow spherical apoferritin was stable over a wide pH range, 3.40-10.0, and the ferrihydrite core was stable over the pH range 2.10-10.0. The apoferritin subunits underwent aggregation below pH 0.80, whereas the ferrihydrite cores aggregated below pH 2.10 as a result of the disassembly of the ferritin shell under the strongly acidic conditions. As the pH decreased from 3.40 to 0.80, apoferritin underwent stepwise disassembly by first forming a hollow sphere with two holes, then a headset-shaped structure, and, finally, rodlike oligomers. As the pH was increased from pH 1.96, the disassembled rodlike oligomers recovered only to the headset-shaped structure, and the disassembled headset-shaped intermediates recovered only to the hollow spherical structure with two hole defects. The apoferritin hole defects that formed during the disassembly process did not heal as the pH was increased to neutral or slightly basic conditions. The pH-induced apoferritin disassembly and reassembly processes were not fully reversible, although they were pseudoreversible over a limited pH range, between 10.0 and 2.66.

Citing Articles

Bioengineered protein nanocarrier facilitating siRNA escape from lysosomes for targeted RNAi therapy in glioblastoma.

Jin Y, Zhang B, Li J, Guo Z, Zhang C, Chen X Sci Adv. 2025; 11(8):eadr9266.

PMID: 39970222 PMC: 11838010. DOI: 10.1126/sciadv.adr9266.


Harnessing macrophage-drug conjugates for allogeneic cell-based therapy of solid tumors via the TRAIN mechanism.

Taciak B, Bialasek M, Kubiak M, Marszalek I, Gorczak M, Osadchuk O Nat Commun. 2025; 16(1):1327.

PMID: 39900573 PMC: 11790938. DOI: 10.1038/s41467-025-56637-9.


Design and application of ferritin-based nanomedicine for targeted cancer therapy.

Zhang B, Fan K Nanomedicine (Lond). 2025; 20(5):481-500.

PMID: 39895329 PMC: 11875477. DOI: 10.1080/17435889.2025.2459056.


Challenges in Exploiting Human H Ferritin Nanoparticles for Drug Delivery: Navigating Physiological Constraints.

Macone A, Cappelletti C, Incocciati A, Piacentini R, Botta S, Boffi A Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024; 16(6):e2016.

PMID: 39541599 PMC: 11655439. DOI: 10.1002/wnan.2016.


The self-assembled nanoparticle-based multi-epitope influenza mRNA vaccine elicits protective immunity against H1N1 and B influenza viruses in mice.

Di Y, Zhang C, Ren Z, Jiang R, Tang J, Yang S Front Immunol. 2024; 15:1483720.

PMID: 39445022 PMC: 11497263. DOI: 10.3389/fimmu.2024.1483720.